SCHEMBL29772302

SCHEMBL29772302

C#C[C@H]1C[C@@H](n2cc(-c3ccn(C)n3)c3c(NCc4ccc(OC)cc4OC)ncnc32)C[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 3/20 0.36
▸ CYP1A2 P05177 15/20 0.35
▸ CYP3A4 P08684 15/20 0.35
▸ CYP2C19 P33261 14/20 0.35
▸ TSHR P16473 12/20 0.35
▸ CYP2D6 P10635 12/20 0.35
▸ ALDH1A1 P00352 10/20 0.35
▸ CLK4 Q9HAZ1 8/20 0.35
▸ USP2 O75604 5/20 0.35
▸ PRMT5 O14744 2/20 0.35
▸ WDR77 Q9BQA1 2/20 0.35
▸ CYP2C9 P11712 9/20 0.35
▸ HSD17B10 Q99714 7/20 0.35
▸ LMNA P02545 4/20 0.35
▸ HIF1A Q16665 4/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ ALOX15 P16050 3/20 0.35
▸ MAPK1 P28482 5/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015920 0.91 METTL3 (0.38) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772286 0.89 METTL3 (0.39) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL25016861 0.89 METTL3 (0.39) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL30106842 0.89 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL23313891 0.89 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772290 0.89 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772309 0.86 CYP1A2 (0.38) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL25016859 0.85 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL23273903 0.85 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772283 0.85 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4048674-A2 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2022-08-31 — — EP disclosed
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
Send feedback